Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients (Q44423486)

2 December 2017

Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients (English)

1 reference

2 December 2017

1 reference

7

1 reference

2 December 2017

Geert J Behets

3

0 references

Marc E. De Broe

8

object named as

Marc E De Broe

1 reference

2 December 2017

9

Patrick C D'Haese

1 reference

2 December 2017

An R J Bervoets

1

1 reference

2 December 2017

Goce B Spasovski

2

1 reference

2 December 2017

Geert Dams

4

1 reference

2 December 2017

Momir H Polenakovic

5

1 reference

2 December 2017

Katica Zafirovska

6

1 reference

2 December 2017

1 May 2003

1 reference

American Journal of Kidney Diseases

2 December 2017

1 reference

2 December 2017

41

1 reference

2 December 2017

997-1007

1 reference

2 December 2017

5

1 reference

Renal bone disease 1990: an unmet challenge for the nephrologist

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Risk factors for vertebral fractures in renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Renal osteodystrophy in predialysis patients without stainable bone aluminum. A cross-sectional bone-histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Circulating biochemical markers of bone remodeling in uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Serum type I procollagen peptide: a non-invasive index of bone formation in patients on haemodialysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by CAPD

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Increased serum strontium levels in dialysis patients: an epidemiological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Increased bone strontium levels in hemodialysis patients with osteomalacia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Bone aluminum and histomorphometric features of renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

The evolution of osteomalacia in the rat with acute aluminum toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

High bone turnover associated with an aluminum-induced impairment of bone mineralization

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Bone ultrastructure and x-ray microanalysis of aluminum-intoxicated hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Histomorphometric evidence of deleterious effect of aluminum on osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Bone disease in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Pyridinium crosslinks in patients on haemodialysis and continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Invasive versus non-invasive diagnosis of renal bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

The evolution of assays for parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Adynamic Bone Disease in Uremia: May It Be Idiopathic? Is It an Actual Disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Adynamic bone disease in patients with uremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900197-5

7 January 2021

10.1016/S0272-6386(03)00197-5

Identifiers

DOI

1 reference

2 December 2017

1 reference